ArriVent BioPharma Ownership | Who Owns ArriVent BioPharma?


OverviewForecastFinancialsChart

ArriVent BioPharma Ownership Summary


ArriVent BioPharma is owned by 96.04% institutional investors, 8.24% insiders. Hhlr advisors is the largest institutional shareholder, holding 12.81% of AVBP shares.

AVBP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockArriVent BioPharma96.04%8.24%-4.28%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Hhlr advisors4.48M12.81%$82.74M
Infinitum asset management3.87M11.05%$71.38M
Suvretta capital management3.70M10.58%$68.33M
Fmr3.41M9.73%$62.87M
Orbimed advisors3.03M8.65%$55.85M
Blackrock funding, inc. /de2.05M5.85%$37.75M
Vanguard group2.03M5.80%$37.44M
Octagon capital advisors lp1.97M5.63%$36.37M
Novo1.94M5.55%$35.83M
Sofinnova investments1.70M4.85%$31.31M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Infinitum asset management3.87M13.13%$71.38M
Octagon capital advisors lp1.97M5.51%$36.37M
Novo1.94M2.31%$35.83M
Hhlr advisors4.48M2.02%$82.74M
Suvretta capital management3.70M1.75%$68.33M
Sofinnova investments1.70M1.71%$31.31M
Orbimed advisors3.03M1.32%$55.85M
Fund 1 investments619.85K1.27%$11.44M
General catalyst group management1.49M0.91%$27.58M
Hidden lake asset management lp314.04K0.74%$5.79M

Top Buyers

HolderShares% AssetsChange
Fmr3.41M0.00%1.35M
Vanguard group2.03M0.00%545.99K
Infinitum asset management3.87M13.13%450.00K
Ubs group497.60K0.00%411.01K
Morgan stanley392.02K0.00%290.67K

Top Sellers

HolderShares% AssetsChange
Cormorant asset management, lp---585.46K
Hidden lake asset management lp314.04K0.74%-292.81K
Squarepoint ops128.31K0.00%-76.05K
Weiss asset management lp---53.79K
Verition fund management15.04K0.00%-41.46K

New Positions

HolderShares% AssetsChangeValue
Franklin resources256.42K0.00%256.42K$4.73M
Burkehill global management, lp100.00K0.10%100.00K$1.84M
Anson funds management lp99.89K0.17%99.89K$1.84M
Quest partners41.45K0.05%41.45K$764.73K
Corient ia33.50K0.46%33.50K$618.08K

Sold Out

HolderChange
Parkside financial bank & trust-20.00
Quadrant capital group-21.00
Ronald blue trust-39.00
Nelson, van denburg & campbell wealth management group-996.00
Virtus etf advisers-2.75K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20259615.66%33,618,96315.59%961.30%498.89%3042.86%
Mar 31, 20257-91.14%11,264,335-59.25%350.53%4-92.98%--100.00%
Dec 31, 20248120.90%28,465,9279.87%841.42%587.41%11266.67%
Sep 30, 20246726.42%25,908,14019.65%771.85%5458.82%3-57.14%
Jun 30, 202453-21,652,506-0.91%641.52%34-35.85%7-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 30, 2024HILLHOUSE INVESTMENT MANAGEMENT, LTD.-Buy$10.00M
Jan 30, 2024ORBIMED ADVISORS LLC Buy$4.00M
Jan 30, 2024GORDON CARL L Buy$4.00M
Jan 30, 2024HEALY JAMES-Buy$8.00M

Insider Transactions Trends


DateBuySell
2025 Q2--
2024 Q14-

AVBP Ownership FAQ


Who Owns ArriVent BioPharma?

ArriVent BioPharma shareholders are primarily institutional investors at 96.04%, followed by 8.24% insiders and -4.28% retail investors. The average institutional ownership in ArriVent BioPharma's industry, Biotech Stocks , is 295.31%, which ArriVent BioPharma falls below.

Who owns the most shares of ArriVent BioPharma?

ArriVent BioPharma’s largest shareholders are Hhlr advisors (4.48M shares, 12.81%), Infinitum asset management (3.87M shares, 11.05%), and Suvretta capital management (3.7M shares, 10.58%). Together, they hold 34.44% of ArriVent BioPharma’s total shares outstanding.

Does Blackrock own ArriVent BioPharma?

BlackRock is not among the top 10 institutional shareholders of ArriVent BioPharma.

Who is ArriVent BioPharma’s biggest shareholder by percentage of total assets invested?

Infinitum asset management is ArriVent BioPharma’s biggest shareholder by percentage of total assets invested, with 13.13% of its assets in 3.87M ArriVent BioPharma shares, valued at 71.38M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools